Article
MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Gene - 10 Sept 2017
Nabhan Marwa, Louka Manal L, Khairy Eman, Tash Fathy, Ali-Labib Randa, El-Habashy Safinaz
Abstract excerpt
Acute lymphoblastic leukemia (ALL) is the most common pediatric hematologic tumor. MiR-181a was expected to have a role in the development of hematological malignancies; it might act as tumor suppressor or oncogene. Smad7 was selected as miR-181a target pair. It is a negative regulator for the TGF-β1 signaling pathway. In this study, relative expression levels of miR-181a by quantitative reverse transcriptase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
